High-dose chemotherapy and stem cell transplant compared to conventional therapy for children with high-risk neuroblastoma | Cochrane

Despite the development of new treatment options, the prognosis of high-risk neuroblastoma patients still remains poor; in more than half of patients the disease returns. Stem cell rescue replaces blood-forming stem cells that were destroyed by high-dose chemotherapy in order to recover the bone ...